Takuro Sakagami
0000-0002-9057-1127
Kumamoto University
7 papers found
Refreshing results…
Osimertinib as first-line treatment for elderly patients with advanced EGFR mutation-positive non-small cell lung cancer in a real-world setting (OSI-FACT-EP)
Combination bezafibrate and nivolumab treatment of patients with advanced non–small cell lung cancer
TGFβ Signaling Activated by Cancer-Associated Fibroblasts Determines the Histological Signature of Lung Adenocarcinoma
Severe pulmonary alveolar proteinosis with respiratory failure treated by intrapulmonary percussive ventilation
Serum Anti-interferon-γ Autoantibody Titer as a Potential Biomarker of Disseminated Non-tuberculous Mycobacterial Infection
The association between tumor burden and severe immune-related adverse events in non-small cell lung cancer patients responding to immune-checkpoint inhibitor treatment
Patient ethnicity and causative species determine the manifestations of anti-interferon-gamma autoantibody-associated nontuberculous mycobacterial disease: a review
Missing publications? Search for publications with a matching author name.